# Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)

> **NCT00632762** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 80 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** mantadix

## Key facts

- **NCT ID:** NCT00632762
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00632762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00632762, "Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00632762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*